ARIBIO Holdings Inc.
Prices may be delayed up to 20 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| 290690.KQ | 301080.SZ | ABVX | ARQT | ALMS | ACXP | |
|---|---|---|---|---|---|---|
| Market cap | 154.89B | 15.95B | 8.19B | 4.02B | 885.34M | 6.39M |
| P/E (TTM) | — | 88.1 | — | 138.9 | — | — |
| Forward P/E | — | — | -24.5 | 23.9 | -2.4 | -0.7 |
| Price/book | — | 6.0 | 18.2 | 18.2 | 1.9 | 0.7 |
| Dividend yield | — | 0.62% | — | — | — | — |
| 1-year change | −26.73% | +61.69% | +2.07% | +65.67% | +49.22% | −82.54% |
| Today | +0.86% | −2.40% | +1.29% | −2.64% | +2.09% | +0.88% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 20 min.
Latest news
All 290690.KQ news ›AriBio, Fosun, And Alzheimer's Disease: Close, But Perhaps Not Enough
(OTCMKTS:SFOSF) Seeking Alpha - AriBio is nearing phase 3 results for AR1001, a phosphodiesterase-5 inhibitor that limits peroxynitrite-mediated damage in Alzheimer's disease. - Shanghai Fosun Pharmaceuticals (SFOSF) secured regional…
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
-
biz.chosun.com2
-
en.sedaily.com2
-
finance.biggo.com2
-
koreabiomed.com2
-
seekingalpha.com1
Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 9 articles, not a forecast.